NCT04931615View on ClinicalTrials.gov

ARTISS a Single-centre Randomised Control Study

PHASE4CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2023

Conditions
Breast NeoplasmsMammaplasty
Interventions
DRUG

ARTISS 4mL Fibrin Sealant Topical Solution (Frozen)

Wound sealant

OTHER

no ARTISS

Wound closed without sealant

Trial Locations (1)

CM1 7ET

Mid and South Essex NHS Foundation Trust, Broomfield

All Listed Sponsors
lead

Mid and South Essex NHS Foundation Trust

OTHER